Pediatric cancer relapse prediction has emerged as a critical development in the ongoing battle against childhood cancers, particularly for conditions like brain tumors or gliomas.Recent advancements in AI cancer prediction have significantly improved the ability to anticipate relapse risk, outperforming traditional methods and providing hope for better patient outcomes.